Riskpilot← Back to searchSign inGet full accessXO LAB ApS
APSBankruptCVR 40155929Amager Strandvej 114C, 8. mfRetail sale of cosmetic and toilet articles · NACE 4775Est. 20191 employees
Revenue 2023
DKK 42K
-89% vs 2022
EBITDA margin
100.0%
-1% vs 2022
Equity ratio
100.0%
Financial strength
Net profit 2023
DKK 1K
+1191% vs 2022
| Revenue | DKK 42K | -89% |
| EBITDA | DKK 42K | -1% |
| Net profit | DKK 1K | +1191% |
| Total assets | DKK 67K | -82% |
| Equity | DKK 67K | +104% |
| Employees | 1 | — |
Legal name
XO LAB ApS
CVR number
40155929
Legal form
Anpartsselskab
NACE code
4775 · Retail sale of cosmetic and toilet articles
Founded
10. januar 2019
Share capital
DKK 66.666
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at drive virksomhed med fabrikation og handel af livstilsprodukter og hermed beslægtet virksomhed.
Address
Amager Strandvej 114C, 8. mf
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | -282 | -83 | 826 | 382 | 42 |
| Staff expenses | -565 | -512 | -619 | -339 | -0 |
| EBITDA | -786 | -595 | 207 | 42 | 42 |
| Depreciation & amort. | -71 | -82 | -83 | -16 | -20 |
| EBIT | -857 | -677 | 124 | 26 | 22 |
| Net financials | -12 | -20 | -123 | -26 | -21 |
| Profit before tax | -941 | -697 | 2 | 0 | 1 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -941 | -697 | 2 | 0 | 1 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 1.661 | 1.096 | 1.173 | 363 | 67 |
| Equity | -874 | -387 | -1.570 | -1.570 | 67 |
| Long-term debt | 1.184 | 0 | 1.184 | 1.184 | 0 |
| Short-term debt | 1.351 | 1.483 | 1.558 | 748 | 0 |
| Total debt | 2.535 | 1.483 | 2.742 | 1.932 | 0 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20192023
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20192023
Return on equity
1.5%
This company
18.4%
Market median
-92% vs market
20192023
Net profit margin
2.4%
This company
8.1%
Market median
-70% vs market
20192023
Asset turnover
0.63×
This company
1.12×
Market median
-44% vs market
20192023
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20192023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-10 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PJ Unofficial title | Unofficial title | 2025 | — | — |
KN Management | Management | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
K.H. ApS HOLDING | Company | 100.0% | 100.0% | 2020 |
LoveMondays ApS | Company | 10.0% | 10.0% | 2019 |
LEHRMANN FAMILY ApS | Company | 10.0% | 10.0% | 2019 |
FREEWAY HOLDING ApS | Company | 10.0% | 10.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
K.H. ApS HOLDING
XO LAB ApS Board members of XO LAB ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Preben Jakobsen | Unofficial title | 0 companies |
| Kristoffer Nikolaj Hjerrild Ovesen | Management | 0 companies |
| Jan Dal Lehrmann | Chairman | 0 companies |
| Mia Therese Wagner | Board of Directors | 0 companies |